Comparison of oxidative stress markers in 3 matrices (EBC, blood and urine) in patients with occupational lung fibrosis and control subjects Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Interleukin-2 in blood serum (BS), expired air condensate (EAC) and nazal lavage fluid (NLF) in children with bronchial asthma (BA) Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Levels of markers in blood and EBC in pneumoconioses Source: Annual Congress 2008 - Occupational lung diseases Year: 2008
Measurement of prostaglandinE2 (PGE2 ) and thromboxaneB2 (TXB2 ) in exhaled breath condensate (EBC) in healthy volunteers Source: Eur Respir J 2002; 20: Suppl. 38, 510s Year: 2002
Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Thromboxane B2 (TXB2) urine levels during long term treatment with montelukast (M) in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
The influence of antileukotriene therapy with montelukast (M) on thromboxane B2 /leukotriene E4 (TXB2 /LTE4 ) ratio in the urine of asthmatic subjects and other inflammatory markers Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2011; 39: 59-66 Year: 2012
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2012; 39: 59-66 Year: 2012
Intra- and inter-subject variability of LTB4 in exhaled breath condensate samples of healthy subjects (calves) Source: Eur Respir J 2003; 22: Suppl. 45, 38s Year: 2003
Lung function tests (LFT) and arterial blood gases (ABG) in smoker (S) and non-smoker (NS) workers with occupational exposure to asbestos Source: Eur Respir J 2002; 20: Suppl. 38, 127s Year: 2002
Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Eicosanoid concentrations in induced sputum (IS) and exhaled breath condensate (EBC) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA) Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004
Comparison between exhaled and bronchoalveolar lavage (BAL) levels of hydrogen peroxide (H2 O2 ) in patients with diffuse interstitial lung diseases (DILD) Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
Blood eosinophil counts in COPD patients compared to controls Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019 Year: 2019